Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for the CTX120 multiple myeloma study is displayed in place of a 403 Forbidden error, with details about the study, participants, locations, and outcome measures.
    Difference
    47%
    Check dated 2026-11-08T14:11:38.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-01T15:38:53.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T14:29:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T14:43:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now shows revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:13:50.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page previously showing a 403 Forbidden message (and its HTML) was removed, likely restoring normal access to the study details content.
    Difference
    0.5%
    Check dated 2026-09-27T18:06:50.000Z thumbnail image

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.